Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A three-level model of diffuse idiopathic skeletal hyperostosis (DISH): Integrating susceptibility, activation, and clinical trajectories.

Bone·2026

Same author

Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform.

The journal of prevention of Alzheimer's disease·2024

Same author

[National protocol for diagnosis and care of retinopathy of prematurity: Summary for the attending physician].

Journal francais d'ophtalmologie·2024

Same author

Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA).

European journal of internal medicine·2024

Same author

[COVID-19 presenting with nystagmus].

Archivos de la Sociedad Espanola de Oftalmologia·2024

Same author

Advancing ocular safety research: A comprehensive examination of benzocaine acute exposure without animal testing.

Toxicology letters·2024

Search research articles

Related Experiment Videos

Circulating cytokines in active polymyalgia rheumatica.

L Alvarez-Rodríguez¹, M Lopez-Hoyos, C Mata

¹Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.

Annals of the Rheumatic Diseases

|March 4, 2009

Summary

This summary is machine-generated.

Active polymyalgia rheumatica (PMR) shows elevated serum interleukin-6 (IL6) levels, which decrease with corticosteroid treatment. This suggests IL6 originates from inflamed tissues, not circulating monocytes, offering potential therapeutic insights.

Related Experiment Videos

Area of Science:

Rheumatology
Immunology
Molecular Biology

Background:

Polymyalgia rheumatica (PMR) is an inflammatory condition affecting older adults.
The precise cytokine profile and cellular sources in active PMR remain incompletely understood.

Purpose of the Study:

To characterize the circulating cytokine profile in polymyalgia rheumatica (PMR).
To identify the cellular origins of these circulating cytokines in PMR patients.

Main Methods:

Cytometric bead array and ELISA were used to measure serum cytokines in 34 active untreated PMR patients and 17 healthy controls (HC).
Intracellular cytokine analysis was performed on CD3+ (T cells) and CD14+ (monocytes) cells via flow cytometry.
Peripheral blood mononuclear cells (PBMCs) were stimulated in vitro to assess cytokine production.

Main Results:

Significantly higher serum levels of interleukin-6 (IL6) were observed in active PMR patients compared to HC.
Corticosteroid (CS) treatment led to a reduction in serum IL6 levels.
Circulating monocytes and T cells in PMR patients did not exhibit increased proinflammatory cytokine production compared to HC.

Conclusions:

Active PMR is associated with elevated serum IL6, which is responsive to CS treatment.
The cellular source of elevated IL6 in PMR is likely inflamed tissue rather than circulating monocytes.
Understanding the cytokine profile and cellular sources may reveal novel therapeutic strategies for PMR.